RxDoctor Payments Data

Douglas Vandaele, MD

Otolaryngology/Facial Plastic Surgery · Iowa City, IANPI 1821082587

Payments from drug & device makers

What this record shows

Inspire Medical Systems, Inc. accounts for 96.0% of it on its own, with 1 other manufacturer making up the rest. 2025 is the largest year on record at $1,263, more than ten times the $114 reported in 2023.

$1,552in general payments, 2019–2025

Across 13 payments — averaging $119.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inspire Medical Systems, Inc.$1K
  • Checkpoint Surgical, Inc$62
$317,166in research payments, 2019–2025

Across 65 payments — averaging $4879.48 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Inspire Medical Systems, Inc.$317K

What the payments were for

  • Travel & lodging$85855%
  • Food & beverage$69445%

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few otolaryngology/facial plastic surgery providers in Iowato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$66,944
Medicare patients
470
Services billed
1,197

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin37$291
Azithromycin17$117
Azelastine Hcl14$96

Paid to pharmacies, not to this prescriber.

Other otolaryngology/facial plastic surgery in Iowa City

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →